Clinical Trials Browser

Unknown × Recurrence × Docetaxel × Clear all

NCT02007148 2019-02-27

MICADO

Phase 2 Unknown

Neoplasm Metastasis, Recurrence

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Phase 2 Unknown

Recurrence, Sarcoma